164 related articles for article (PubMed ID: 19500982)
1. Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2009 Aug; 19(15):4274-9. PubMed ID: 19500982
[TBL] [Abstract][Full Text] [Related]
2. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
[TBL] [Abstract][Full Text] [Related]
3. Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: impacting hERG liability via aryl modifications.
McBriar MD; Guzik H; Shapiro S; Xu R; Paruchova J; Clader JW; O'neill K; Hawes B; Sorota S; Margulis M; Tucker K; Weston DJ; Cox K
Bioorg Med Chem Lett; 2006 Aug; 16(16):4262-5. PubMed ID: 16753297
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
Kasai S; Kamata M; Masada S; Kunitomo J; Kamaura M; Okawa T; Takami K; Ogino H; Nakano Y; Ashina S; Watanabe K; Kaisho T; Imai YN; Ryu S; Nakayama M; Nagisa Y; Takekawa S; Kato K; Murata T; Suzuki N; Ishihara Y
J Med Chem; 2012 May; 55(9):4336-51. PubMed ID: 22490048
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of 2-piperidin-4-yl-actamide derivatives for hERG blocking and MCH R1 antagonistic activities.
Moorthy NS; Ramos MJ; Fernandes PA
Curr Drug Discov Technol; 2012 Mar; 9(1):25-38. PubMed ID: 22235926
[TBL] [Abstract][Full Text] [Related]
6. Lead optimization of melanin concentrating hormone receptor 1 antagonists with low hERG channel activity.
Judd AS; Souers AJ; Kym PR
Curr Top Med Chem; 2008; 8(13):1152-7. PubMed ID: 18782010
[TBL] [Abstract][Full Text] [Related]
7. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
[TBL] [Abstract][Full Text] [Related]
8. Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity.
Judd AS; Souers AJ; Wodka D; Zhao G; Mulhern MM; Iyengar RR; Gao J; Lynch JK; Freeman JC; Falls HD; Brodjian S; Dayton BD; Reilly RM; Gintant G; Limberis JT; Mikhail A; Leitza ST; Houseman KA; Diaz G; Bush EN; Shapiro R; Knourek-Segel V; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
Bioorg Med Chem Lett; 2007 Apr; 17(8):2365-71. PubMed ID: 17350253
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity.
Kameda M; Kobayashi K; Ito H; Miyazoe H; Tsujino T; Nakama C; Kawamoto H; Ando M; Ito S; Suzuki T; Kanno T; Tanaka T; Tahara Y; Tani T; Tanaka S; Tokita S; Sato N
Bioorg Med Chem Lett; 2009 Aug; 19(15):4325-9. PubMed ID: 19487123
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2.
Chen X; Mihalic J; Fan P; Liang L; Lindstrom M; Wong S; Ye Q; Fu Y; Jaen J; Chen JL; Dai K; Li L
Bioorg Med Chem Lett; 2012 Jan; 22(1):363-6. PubMed ID: 22123324
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.
Mihalic JT; Fan P; Chen X; Chen X; Fu Y; Motani A; Liang L; Lindstrom M; Tang L; Chen JL; Jaen J; Dai K; Li L
Bioorg Med Chem Lett; 2012 Jun; 22(11):3781-5. PubMed ID: 22542010
[TBL] [Abstract][Full Text] [Related]
13. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
[TBL] [Abstract][Full Text] [Related]
14. 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).
Lim CJ; Kim SH; Lee BH; Oh KS; Yi KY
Bioorg Med Chem Lett; 2012 Jan; 22(1):427-30. PubMed ID: 22137790
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.
Becknell NC; Dandu RR; Lyons JA; Aimone LD; Raddatz R; Hudkins RL
Bioorg Med Chem Lett; 2012 Jan; 22(1):186-9. PubMed ID: 22153342
[TBL] [Abstract][Full Text] [Related]
16. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
Högberg T; Frimurer TM; Sasmal PK
Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists.
Lim CJ; Kim JY; Lee BH; Oh KS; Yi KY
Bioorg Med Chem Lett; 2013 Mar; 23(6):1736-9. PubMed ID: 23411080
[TBL] [Abstract][Full Text] [Related]
18. Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.
Lau JF; Jeppesen CB; Rimvall K; Hohlweg R
Bioorg Med Chem Lett; 2006 Oct; 16(20):5303-8. PubMed ID: 16908150
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists.
Johansson A
Expert Opin Ther Pat; 2011 Jun; 21(6):905-25. PubMed ID: 21492020
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition.
Roth GJ; Heckel A; Kley JT; Lehmann T; Müller SG; Oost T; Rudolf K; Arndt K; Budzinski R; Lenter M; Lotz RR; Schindler M; Thomas L; Stenkamp D
Bioorg Med Chem Lett; 2015 Aug; 25(16):3270-4. PubMed ID: 26077492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
